ProQR Therapeutics NV (NASDAQ:PRQR)
| 1.50 BATS BZX Real-Time Price As of 11:43am ET |  +0.02 / +1.35%Today’s Change | 0.72 Today|||52-Week Range 3.85 | -59.46% Year-to-Date |
Latest PRQR News | Press Releases
No recent news for ProQR Therapeutics NV.
Today’s Trading
| Previous close | 1.48 |
| Today’s open | 1.50 |
| Day’s range | 1.50 - 1.52 |
| Volume | 6,510 |
| Average volume (3 months) | 259,800 |
| Market cap | $129.5M |
Data as of 11:43am ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | +15.83% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +165.11% |
| P/E ratio | NM |
| Price/Sales | 62.48 |
| Price/Book | 1.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ETONEton Pharmaceuticals... | -0.01 | -0.22% |
| GRTSGritstone bio Inc | -0.05 | -3.85% |
| ESPREsperion Therapeutic... | -0.01 | -0.87% |
| EPIXESSA Pharma Inc | 0.00 | 0.00% |
Data as of 12:08pm ET, 09/21/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $4.2M |
| Annual profit (last year) | -$68.4M |
| Net profit margin | -1,612.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leiden, Zuid-holland |
Forecasts
